{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:31:13Z","timestamp":1787056273036,"version":"build-2736575974"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Objectives:<\/jats:title>\n                    <jats:p>Restless leg syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move the legs, often accompanied by unpleasant sensations such as tingling, crawling, or aching. Symptoms typically worsen during periods of rest or inactivity, particularly in the evening or at night. This scoping review aimed to synthesize the existing literature on the efficacy of cannabis and cannabinoids in alleviating symptoms associated with RLS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive search of electronic databases\u2014including PubMed, Embase, Scopus, Cochrane Library, Google Scholar, ClinicalKey, and ClinicalTrials.gov\u2014was conducted from database inception to April 30, 2025. Various keywords related to cannabis, cannabinoids, and RLS were used to identify relevant clinical studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 5,370 records were identified, of which seven studies met the inclusion criteria for final review. The evidence suggests that cannabis or cannabidiol may improve or prevent RLS symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      Current evidence indicates that cannabis, in various forms, may alleviate or prevent symptoms of RLS through multiple mechanisms. However, the existing literature is limited to case reports, cross-sectional surveys, and\n                      <jats:italic toggle=\"yes\">post hoc<\/jats:italic>\n                      analyses. In the absence of high-quality randomized controlled trials, the evidence is insufficient to support clinical recommendations at this time.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aian.aian_1168_25","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:14Z","timestamp":1787032814000},"page":"510-518","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Cannabinoids use on Symptoms of Restless Leg Syndrome among Adults: A Scoping Review"],"prefix":"10.4103","volume":"29","author":[{"given":"Sucheta","family":"Saha","sequence":"first","affiliation":[{"name":"Department of Psychiatry, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Tripathi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh Kumar","family":"Saini","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Division of Sleep Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Neurology, All India Institute of Medical Sciences, Bibinagar, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Division of Sleep Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"R2-20260818","doi-asserted-by":"crossref","first-page":"e0140632","DOI":"10.1371\/journal.pone.0140632","article-title":"The humanistic and economic burden of restless legs syndrome","volume":"10","author":"Durgin","year":"2015","journal-title":"PLoS One"},{"key":"R3-20260818","first-page":"S207","article-title":"The real burden of restless legs syndrome: Clinical and economic outcomes","volume":"18","author":"Salas","year":"2012","journal-title":"Am J Manag Care"},{"key":"R4-20260818","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11136-006-9142-8","article-title":"Burden of restless legs syndrome on health-related quality of life","volume":"16","author":"Kushida","year":"2007","journal-title":"Qual Life Res"},{"key":"R5-20260818","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fnagi.2017.00171","article-title":"Restless legs syndrome: From pathophysiology to clinical diagnosis and management","volume":"9","author":"Guo","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"R6-20260818","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sleep.2016.01.017","article-title":"Guidelines for the first-line treatment of restless legs syndrome\/Willis\u2013Ekbom disease, prevention and treatment of dopaminergic augmentation: A combined task force of the IRLSSG, EURLSSG, and the RLS-foundation","volume":"21","author":"Garcia-Borreguero","year":"2016","journal-title":"Sleep Med"},{"key":"R7-20260818","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5664\/jcsm.11390","article-title":"Treatment of restless legs syndrome and periodic limb movement disorder: An American Academy of Sleep Medicine clinical practice guideline","volume":"21","author":"Winkelman","year":"2025","journal-title":"J Clin Sleep Med"},{"key":"R8-20260818","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5334\/tohm.739","article-title":"A narrative review of the lesser known medications for treatment of restless legs syndrome and pathogenetic implications for their use","volume":"13","author":"Yeh","year":"2023","journal-title":"Tremor Other Hyperkinetic Mov"},{"key":"R9-20260818","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.sleep.2013.05.016","article-title":"The long-term treatment of restless legs syndrome\/Willis\u2013Ekbom disease: Evidence-based guidelines and clinical consensus best practice guidance: A report from the International Restless Legs Syndrome Study Group","volume":"14","author":"Garcia-Borreguero","year":"2013","journal-title":"Sleep Med"},{"key":"R10-20260818","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.3390\/ijms23063344","article-title":"Cannabinoids: Therapeutic use in clinical practice","volume":"23","author":"Pagano","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R11-20260818","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2015","journal-title":"Biol Psychiatry"},{"key":"R12-20260818","doi-asserted-by":"crossref","first-page":"2054358120954944","DOI":"10.1177\/2054358120954944","article-title":"Cannabis use for restless legs syndrome and uremic pruritus in in patients treated with maintenance dialysis: A survey","volume":"7","author":"Samaha","year":"2020","journal-title":"Can J Kidney Health Dis"},{"issue":"Suppl 1","key":"R13-20260818","doi-asserted-by":"crossref","first-page":"A246","DOI":"10.1093\/sleep\/zsac079.556","article-title":"0559 prevalence of cannabis use in patients with restless leg syndrome for symptomatic relief","volume":"45","author":"Kachechian","year":"2022","journal-title":"Sleep"},{"key":"R14-20260818","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11325-019-01978-1","article-title":"More evidence of cannabis efficacy in restless legs syndrome","volume":"24","author":"Ghorayeb","year":"2020","journal-title":"Sleep Breath"},{"key":"R16-20260818","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/j.pain.0000000000001929","article-title":"Cannabinoids, cannabis, and cannabis-based medicine for pain management: A systematic review of randomised controlled trials","volume":"162","author":"Fisher","year":"2021","journal-title":"Pain"},{"key":"R18-20260818","first-page":"2127","article-title":"Methodological quality of case series studies: An introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"key":"R19-20260818","first-page":"423","article-title":"Topical magnesium-coordinated cannabidiolic acid (CBDA) for the treatment of restless leg syndrome","volume":"14","author":"Kimless","year":"2025","journal-title":"J Sleep Disord Ther"},{"key":"R20-20260818","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.explore.2021.01.004","article-title":"The intersection between integrative medicine and neuropathic pain: A case report","volume":"18","author":"Zarabian","year":"2022","journal-title":"Explore (NY)"},{"key":"R21-20260818","doi-asserted-by":"crossref","first-page":"626853","DOI":"10.3389\/fpubh.2021.626853","article-title":"Evaluation of patient reported safety and efficacy of cannabis from a survey of medical cannabis patients in Canada","volume":"9","author":"Cahill","year":"2021","journal-title":"Front Public Health"},{"key":"R22-20260818","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JPD-202260","article-title":"Cannabis in Parkinson\u2019s Disease: The Patients\u2019 View","volume":"11","author":"Yenilmez","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"R23-20260818","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s42238-021-00061-5","article-title":"Reasons for cannabidiol use: A cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems","volume":"3","author":"Moltke","year":"2021","journal-title":"J Cannabis Res"},{"issue":"Suppl 2","key":"R24-20260818","first-page":"S372","article-title":"Sustained relief of refractory restless leg syndrome with cannabinoids","volume":"37","author":"Buck","year":"2022","journal-title":"J Gen Int Med"},{"key":"R25-20260818","doi-asserted-by":"crossref","first-page":"2054358120954944","DOI":"10.1177\/2054358120954944","article-title":"Cannabis use for restless legs syndrome and uremic pruritus in in patients treated with maintenance dialysis: A survey","volume":"7","author":"Samaha","year":"2020","journal-title":"Can J Kidney Health Dis"},{"key":"R26-20260818","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.sleep.2017.04.019","article-title":"Cannabis for restless legs syndrome: A report of six patients","volume":"36","author":"Megelin","year":"2017","journal-title":"Sleep Med"},{"key":"R27-20260818","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpainsymman.2020.08.003","article-title":"Nephrologist views regarding cannabinoid use in advanced chronic kidney disease and dialysis: A survey","volume":"61","author":"Collister","year":"2021","journal-title":"J Pain Symptom Manage"},{"key":"R28-20260818","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/ndt\/gfac226","article-title":"Patient views regarding cannabis use in chronic kidney disease and kidney failure: A survey study","volume":"38","author":"Collister","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"R29-20260818","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1089\/can.2021.0158","article-title":"The effect of cannabidiol for restless legs syndrome\/Willis-Ekbom disease in Parkinson\u2019s disease patients with REM sleep behavior disorder: A post hoc exploratory analysis of phase 2\/3 clinical trial","volume":"8","author":"De Almeida","year":"2023","journal-title":"Cannabis Cannabinoid Res"},{"key":"R31-20260818","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.sleep.2017.09.028","article-title":"Willis-Ekbom disease\/restless legs syndrome in patients with opioid withdrawal","volume":"45","author":"Gupta","year":"2018","journal-title":"Sleep Med"},{"key":"R32-20260818","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1389-9457(02)00258-7","article-title":"Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome","volume":"4","author":"Walters","year":"2003","journal-title":"Sleep Med"},{"key":"R33-20260818","first-page":"CD007834","article-title":"Iron for the treatment of restless legs syndrome","volume":"2019","author":"Trotti","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R34-20260818","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s13311-021-01019-4","article-title":"Restless legs syndrome: Contemporary diagnosis and treatment","volume":"18","author":"Gossard","year":"2021","journal-title":"Neurotherapeutics"},{"key":"R35-20260818","doi-asserted-by":"crossref","first-page":"751643","DOI":"10.3389\/fnins.2021.751643","article-title":"The efficacy and safety of pharmacological treatments for restless legs syndrome: Systemic review and network meta-analysis","volume":"15","author":"Zhou","year":"2021","journal-title":"Front Neurosci"},{"key":"R36-20260818","first-page":"603","article-title":"A comprehensive review of cannabis potency in the United States in the last decade","volume":"6","author":"ElSohly","year":"2021","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"R37-20260818","doi-asserted-by":"crossref","first-page":"921493","DOI":"10.3389\/fphar.2022.921493","article-title":"Potency and therapeutic THC and CBD ratios: U.S. cannabis markets overshoot","volume":"13","author":"Pennypacker","year":"2022","journal-title":"Front Pharmacol"},{"key":"R38-20260818","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1054\/plef.2001.0350","article-title":"Endocannabinoids and basal ganglia functionality","volume":"66","author":"Fern\u00e1ndez-Ruiz","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"R39-20260818","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pnpbp.2011.12.004","article-title":"Cannabinoid modulation of the dopaminergic circuitry: Implications for limbic and striatal output","volume":"38","author":"Fitzgerald","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R40-20260818","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1460-9568.2008.06551.x","article-title":"Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity","volume":"29","author":"Adermark","year":"2009","journal-title":"Eur J Neurosci"},{"key":"R41-20260818","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1523\/JNEUROSCI.3695-04.2004","article-title":"Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area","volume":"24","author":"Riegel","year":"2004","journal-title":"J Neurosci"},{"key":"R42-20260818","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1523\/JNEUROSCI.0280-07.2007","article-title":"Combined activation of L-Type Ca2+ channels and synaptic transmission is sufficient to induce striatal long-term depression","volume":"27","author":"Adermark","year":"2007","journal-title":"J Neurosci"},{"key":"R44-20260818","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00213-005-0114-4","article-title":"Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems","volume":"182","author":"Vigan\u00f2","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"R45-20260818","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.npp.1301127","article-title":"Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats","volume":"32","author":"Ellgren","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R46-20260818","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjp.0706757","article-title":"mu opioid and CB1 cannabinoid receptor interactions: Reciprocal inhibition of receptor signaling and neuritogenesis","volume":"148","author":"Rios","year":"2006","journal-title":"Br J Pharmacol"},{"key":"R47-20260818","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0006-8993(00)01981-8","article-title":"Dynorphin B and spinal analgesia: Induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide","volume":"857","author":"Houser","year":"2000","journal-title":"Brain Res"},{"key":"R48-20260818","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(99)01339-5","article-title":"Pharmacological and biochemical interactions between opioids and cannabinoids","volume":"20","author":"Manzanares","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"R49-20260818","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1523\/JNEUROSCI.21-03-00823.2001","article-title":"Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus","volume":"21","author":"Rodr\u00edguez","year":"2001","journal-title":"J Neurosci"},{"key":"R50-20260818","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuroscience.2004.05.015","article-title":"Compartment-specific localization of cannabinoid 1 (CB1) and \u03bc-opioid receptors in rat nucleus accumbens","volume":"127","author":"Pickel","year":"2004","journal-title":"Neuroscience"},{"key":"R51-20260818","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1097\/00001756-200112040-00017","article-title":"CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn","volume":"12","author":"Salio","year":"2001","journal-title":"Neuroreport"},{"key":"R52-20260818","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0269881104040237","article-title":"Repeated administration with Delta9-tetrahydrocannabinol regulates mu-opioid receptor density in the rat brain","volume":"18","author":"Corchero","year":"2004","journal-title":"J Psychopharmacol"},{"key":"R53-20260818","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevNeurobiol.v16.i12.170","article-title":"Cannabinoid\/opioid crosstalk in the central nervous system","volume":"16","author":"Corchero","year":"2004","journal-title":"Crit Rev Neurobiol"},{"key":"R54-20260818","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1212\/WNL.0b013e3181cef824","article-title":"Availability of brain serotonin transporters in patients with restless legs syndrome","volume":"74","author":"Jhoo","year":"2010","journal-title":"Neurology"},{"key":"R55-20260818","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1212\/WNL.59.2.215","article-title":"Evidence for a genetic association between monoamine oxidase A and restless legs syndrome","volume":"59","author":"Desautels","year":"2002","journal-title":"Neurology"},{"key":"R56-20260818","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.smrv.2017.06.002","article-title":"The influence of antidepressants on restless legs syndrome and periodic limb movements: A systematic review","volume":"38","author":"Kolla","year":"2018","journal-title":"Sleep Med Rev"},{"key":"R57-20260818","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1523\/JNEUROSCI.4232-04.2005","article-title":"Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis","volume":"25","author":"K\u00f6falvi","year":"2005","journal-title":"J Neurosci"},{"key":"R58-20260818","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol Rev"},{"key":"R59-20260818","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1476-5381.2009.00434.x","article-title":"Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices","volume":"158","author":"Mendiguren","year":"2009","journal-title":"Br J Pharmacol"},{"key":"R60-20260818","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2006.01.002","article-title":"Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats","volume":"534","author":"Mendiguren","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"R61-20260818","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.5665\/sleep.3934","article-title":"Increased Electroencephalographic High Frequencies during the Sleep Onset Period in Patients with Restless Legs Syndrome","volume":"37","author":"Ferri","year":"2014","journal-title":"Sleep"},{"key":"R62-20260818","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/bs.apha.2018.12.002","article-title":"The neurophysiology of hyperarousal in restless legs syndrome: Hints for a role of glutamate\/GABA","volume":"84","author":"Lanza","year":"2019","journal-title":"Adv Pharmacol"},{"key":"R63-20260818","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.sleep.2014.05.019","article-title":"Restless legs syndrome and central nervous system gamma-aminobutyric acid: preliminary associations with periodic limb movements in sleep and restless leg syndrome symptom severity","volume":"15","author":"Winkelman","year":"2014","journal-title":"Sleep Med"},{"key":"R64-20260818","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ana.25104","article-title":"Targeting hypersensitive corticostriatal terminals in restless legs syndrome","volume":"82","author":"Yepes","year":"2017","journal-title":"Ann Neurol"},{"key":"R65-20260818","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1476-5381.2010.00723.x","article-title":"Adenosine\u2013cannabinoid receptor interactions. Implications for striatal function","volume":"160","author":"Ferr\u00e9","year":"2010","journal-title":"Br J Pharmacol"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_1168_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:01:20Z","timestamp":1787054480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_1168_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_1168_25","relation":{},"ISSN":["0972-2327","1998-3549"],"issn-type":[{"value":"0972-2327","type":"print"},{"value":"1998-3549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2025-11-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}